Intracellular cholesterol: new functions and therapeutic approaches in NSCLC EGFR-TKI resistance
Abstract Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly enhanced survival rates among patients with advanced non-small cell lung cancer (NSCLC) exhibiting EGFR mutations. However, acquired resistance diminishes their therapeutic efficacy over time. Recent inves...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-07-01
|
| Col·lecció: | Lipids in Health and Disease |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12944-025-02559-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|